Detalhe da pesquisa
1.
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation.
Am Heart J
; 264: 123-132, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279840
2.
Transesophageal echocardiographic diagnosis of a WATCHMAN left atrial appendage closure device thrombus 10 years following implantation.
Echocardiography
; 34(1): 128-130, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27862233
3.
Resolution (and Late Recurrence) of WATCHMAN Device-Related Thrombus Following Treatment with Dabigatran.
Echocardiography
; 33(5): 792-795, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26775639
4.
Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.
Circulation
; 127(6): 720-9, 2013 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23325525
5.
Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.
JAMA
; 312(19): 1988-98, 2014 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25399274
6.
5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
J Am Coll Cardiol
; 70(24): 2964-2975, 2017 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29103847
7.
Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial).
Am J Cardiol
; 117(7): 1127-34, 2016 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26993976
8.
Attainment of goals from national guidelines among persons with type 2 diabetes: a cohort study in an academic family medicine setting.
N C Med J
; 66(6): 415-9, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16438097
9.
Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.
JACC Cardiovasc Interv
; 8(15): 1925-1932, 2015 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26627989
10.
Diabetes mellitus is associated with a shift in the temporal risk profile of inhospital death after percutaneous coronary intervention: an analysis of 25,223 patients over 20 years.
Am Heart J
; 145(2): 270-7, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12595844
11.
Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction.
Am Heart J
; 148(3): 493-500, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15389238
12.
Improving in-hospital mortality in the setting of an increasing risk profile among patients undergoing catheter-based reperfusion for an acute myocardial infarction without cardiogenic shock.
J Invasive Cardiol
; 15(12): 711-6, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14660825
13.
Regular use of aspirin and pancreatic cancer risk.
BMC Public Health
; 2: 18, 2002 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-12213184
14.
Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
J Am Coll Cardiol
; 64(1): 1-12, 2014 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24998121
15.
Contrast enhanced transesophageal echocardiographic guidance of left atrial appendage closure device implantation.
J Am Soc Echocardiogr
; 23(9): 1007.e3-4, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20356712
16.
Contraceptive choices of women 35-44 years of age: findings from the behavioral risk factor surveillance system.
Ann Epidemiol
; 19(11): 823-33, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19394863